Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...
BMJ6mon
Factors that predict a poor outcome 5–8 years after the diagnosis of patellofemoral pain: a multicentre observational analysis
Pain severity (100 mm visual analogue scale (VAS)), function (Anterior Knee ... Longer PFP duration and worse AKPS score at baseline predict poor PFP prognosis. Education of health practitioners and ...